Phytic acid-modified CeO2 as Ca2+ inhibitor for a security reversal of tumor drug resistance

Abstract

Supplementary material (further details of the XRD pattern of CeO₂, TEM images, XPS spectra, cellular uptake study, cytotoxicity data, apoptosis study, biodistribution, and biosecurity of nanocerias <i>in vivo</i>, etc.) is available in the online version of this article at 10.1007/s12274-022-4069-0.